Apple Inc. (AAPL) Partners with Emory Healthcare to Power First U.S. Hospital with Its Devices

Emory Hillandale Hospital in Georgia has become the first U.S. hospital to fully operate on Apple Inc.  (NASDAQ:AAPL) devices, signaling a major step in AAPL’s push into health care. The hospital will use iPads, iPhones, Apple Watches, iMacs, and Mac minis, all integrated with Epic, the nation’s leading electronic health record (EHR) software.

Apple Inc. (NASDAQ:AAPL) Partners with Emory Healthcare to Power First U.S. Hospital with Its Devices

An Apple store displaying the latest in consumer electronics, from smartphones to wearables.

Emory executives chose AAPL for its user-friendly design, robust cybersecurity, minimal IT support needs, and reliable hardware. The move follows last July’s widespread CrowdStrike outage, which crippled over 20,000 devices at Emory but left Apple Inc.  (NASDAQ:AAPL) products unaffected, prompting deeper collaboration with AAPL and Epic engineers. Emory Healthcare CEO Dr. Joon Lee called the initiative a potential “game changer,” noting the system will closely monitor the rollout to ensure improved patient care.

Feedback from a pilot program was “phenomenal,” boosting confidence for this full-scale launch. If successful, Emory plans to expand AAPL device use across its 10 hospitals. Dr. Sumbul Desai, vice president of health at Apple Inc.  (NASDAQ:AAPL), said the company is “thrilled” to support Emory in delivering exceptional care, while Epic’s Seth Howard described the integration as a natural evolution of their longstanding partnership with AAPL.

While we acknowledge the potential of AAPL to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk.  If you are looking for an AI stock that is more promising than AAPL and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Cancer Stocks to Invest in for Long-Term Gains and 10 Most Oversold Stocks to Buy According to Billionaires.

Disclosure: None.